Personalized circulating tumor DNA (ctDNA) monitoring for recurrence detection and treatment response assessment in hepatocellular carcinoma (HCC)

被引:0
|
作者
Abdelrahim, M. [1 ]
Esmail, A. [1 ]
He, A. R. [2 ]
Franses, J. [3 ]
Bhan, I. [4 ]
Victor, D. W. [5 ]
Kodali, S. [5 ]
Connor, A. A. [5 ]
Saharia, A. [5 ]
Brdiges, C. [6 ]
Tin, T. [7 ]
Brewer, C. [8 ]
Jurdi, A. [8 ]
Liu, M. C. [9 ]
Ghobrial, R. M. [5 ]
机构
[1] Houston Methodist Neal Canc Ctr, Med Oncol Dept, Floor 24, Houston, TX USA
[2] Georgetown Univ, Comprehens Canc Ctr, Georgetown, WA USA
[3] Harvard Med Sch, Med Oncol Dept, Boston, MA USA
[4] Harvard Med Sch, Massachusetts Gen Hosp Canc Ctr, Med Oncol Dept, Boston, MA USA
[5] Houston Methodist, Liver Transplant, Houston, TX USA
[6] Natera Inc, MA, San Carlos, CA USA
[7] Natera, R&D, San Carlos, CA USA
[8] Natera Inc, Med Oncol Dept, San Carlos, CA USA
[9] Natera Inc, Oncol Dept, San Carlos, CA USA
关键词
D O I
10.1016/j.annonc.2023.09.2106
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
960P
引用
收藏
页码:S600 / S600
页数:1
相关论文
共 50 条
  • [1] Circulating tumor DNA (ctDNA) testing for recurrence and treatment response monitoring in hepatocellular carcinoma (HCC)
    Abdelrahim, M.
    Mejia, A.
    Esmail, A.
    Ouf, M.
    Franses, J. W.
    Bhan, I.
    Sudha, K.
    Brdiges, C.
    Tin, T.
    Brewer, C.
    Aushev, V.
    Palsuledesai, C. C.
    Jurdi, A.
    Liu, M. C.
    Ghobrial, R. M.
    He, A. R.
    [J]. ANNALS OF ONCOLOGY, 2024, 35 : S82 - S82
  • [2] Longitudinal and personalized detection of circulating tumor DNA (ctDNA) for monitoring efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma (HCC).
    Hsu, Chih-Hung
    Lu, Shan
    Abbas, Alex
    Guan, Yinghui
    Zhu, Andrew X.
    Aleshin, Alexey
    Lee, Kyung-Hun
    Lee, Michael Sangmin
    Mahipal, Amit
    Ryoo, Baek-Yeol
    Ding, Beiying
    Spahn, Jessica
    Verret, Wendy
    He, Aiwu Ruth
    Wang, Yulei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Personalized circulating tumor DNA testing for recurrence detection and treatment response monitoring in patients with metastatic invasive lobular carcinoma
    Oesterreich, Steffi
    Tin, Antony
    Rivero-Hinojosa, Samuel
    Fielder, Janie
    Ferguson, Jenifer
    Kalashnikova, Ekaterina
    Rodriguez, Angel
    Liu, Minetta
    Lee, Adrian
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [4] Mutation profiles in circulating tumor DNA (ctDNA) to predict the efficacy of sorafenib treatment in patients with advanced hepatocellular carcinoma (HCC).
    Yang, Ping
    Ji, Guanghui
    Jiang, Qionghui
    Lu, Zejun
    Yu, Yao
    Yang, Yadong
    Jin, Ge
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Feasibility of personalized and tumor informed ctdna testing for recurrence monitoring in post-transplantation hepatocellular carcinoma
    Abdelrahim, M.
    Esmail, A.
    Saharia, A.
    McMillan, R.
    He, A. R.
    Starr, J.
    Dhani, H.
    Aushev, V.
    Malashevich, A. Koyen
    Hook, N.
    Gauthier, P.
    Billings, P.
    Rodriguez, A.
    Ghobrial, R. M.
    [J]. TRANSPLANTATION, 2022, 106 (8S) : 161 - 162
  • [6] Monitoring Treatment Response, Early Recurrence, and Survival in Uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA Biomarkers
    Bellone, Stefania
    McNamara, Blair
    Mutlu, Levent
    Demirkiran, Cem
    Hartwich, Tobias Max Philipp
    Harold, Justin
    Yang-Hartwich, Yang
    Siegel, Eric R.
    Santin, Alessandro D.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [7] Circulating tumor DNA detection in hepatocellular carcinoma
    Cabel, L.
    Proudhon, C.
    Buecher, B.
    Pierga, J. -Y.
    Bidard, F. -C.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (05) : 1094 - 1096
  • [9] Detection of circulating tumor cells (CTCs) in patients with hepatocellular carcinoma (HCC)
    Zee, B. C.
    Wong, C.
    Kuhn, T.
    Howard, R.
    Yeo, W.
    Koh, J.
    Hui, E.
    Chan, A. T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Leveraging personalized circulating tumor DNA monitoring to predict treatment response and recurrence in high-risk endometrial cancer
    Pham, Melissa
    Scalise, Carly Bess
    Kalashnikova, Ekaterina
    Dutta, Punashi
    Chen, Xi
    Narcisse, Subrina
    Rangel, Kelly
    Urbauer, Diana
    Elnaggar, Adam
    Westin, Shannon
    Jazaeri, Amir
    Lu, Karen
    Soliman, Pamela
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A141 - A141